-

ConnectiveRx Named Company of the Year at 2020 PM360 Trailblazer Awards

Company’s Copay ePA solution wins in Persistence/Adherence category

WHIPPANY, N.J.--(BUSINESS WIRE)--ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, today announced it was named Trailblazer 2020 Company of the Year in the supplier/vendor category by PM360, a leading trade magazine for the pharmaceutical, biotech, medical device and diagnostics industries. Nominated for a total of three awards, the company was also awarded top billing in the Persistence/Adherence category for its innovative Copay ePA solution.

For the last 12 years, the PM360 Trailblazer Awards have recognized outstanding companies, marketers, marketing teams, brand managers, and initiatives in healthcare marketing. To reach the finalist phase, companies must show achievement in innovation, talent development, and social responsibility.

“ConnectiveRx was founded with a mission to simplify how patients get on and stay on therapy. We work day in and day out to address the complexities facing patients, providers and pharmaceutical manufacturers through innovation and compassion,” said ConnectiveRx Chief Marketing Officer Danielle Daly. “Our nearly 1700 ConnectiveRx teammates all work with one purpose in mind — help patients connect to a healthier future. We are honored to be recognized by PM360 for delivering on that commitment.”

The PM360 Editorial Advisory Board, comprising forward-thinking leaders from their respective fields, judged nominations across nine overall categories. Winners were selected for their ability to stand out in the complex, ever-changing healthcare environment, and were judged on content, format, success in reaching targeted audience, and overall quality.

Winners were honored during a virtual celebration on October 1st and will be featured in the October issue of PM360.

About ConnectiveRx

ConnectiveRx is a leading technology-enabled biopharmaceutical services company that provides patient and provider support, access and adherence solutions for specialty and branded medications. The company’s services include the industry’s leading patient engagement and access platform (hub services), patient and provider adherence messaging, patient affordability programs, and the iconic Physicians’ Desk Reference, now known as the Prescribers’ Digital Reference. ConnectiveRx's wide array of services and innovative solutions accelerate speed-to-therapy and increase access and adherence resulting in improved outcomes for patients and healthcare overall.

ConnectiveRx has two main campus locations in Whippany, NJ and Pittsburgh, PA with additional locations in New Jersey, Pennsylvania, Missouri and California. To learn more, visit www.connectiverx.com or follow us on Twitter, LinkedIn and Facebook @ConnectiveRx.

Contacts

Danielle Daly, ConnectiveRx
Danielle.Daly@connectiverx.com

ConnectiveRx


Release Versions

Contacts

Danielle Daly, ConnectiveRx
Danielle.Daly@connectiverx.com

Social Media Profiles
More News From ConnectiveRx

ConnectiveRx Earns Top Rankings From McKinsey, Named MM+M Power Partner; Three Leaders Named to PM360 ELITE 100

WHIPPANY, N.J.--(BUSINESS WIRE)--ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, today announced it received top rankings in independent McKinsey research, was named an MM+M Power Partner, and had three executives named to the PM360 ELITE 100. In independent market research conducted by McKinsey & Company, ConnectiveRx earned the highest affordability Net Promoter Score (NPS) and was also recognized as having...

ConnectiveRx Executives Lead Industry Conversations on Access, Launch and Gross-to-Net Challenges

WHIPPANY, N.J.--(BUSINESS WIRE)--ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, today recapped its thought leadership activity over the first half of 2026. The company's pharma commercialization experts presented at industry events, shared perspectives on patient access and gross-to-net (GTN) strategies in key trade publications, and debuted ShieldRx, its new AI-driven pharmacy monitoring solution. Conference Pr...

ConnectiveRx and EagleForce Launch ShieldRx to Stop Pharmacy Misuse Before Claims Are Paid

WHIPPANY, N.J.--(BUSINESS WIRE)--ConnectiveRx and EagleForce launch ShieldRx, a real-time solution to stop pharmacy misuse before claims are paid and protect gross-to-net....
Back to Newsroom